WELLS FARGO & COMPANY/MN
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 72971
SAN FRANCISCO, CA
Position in VRDN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,823,069
-$2,761,403 QoQ
Shares Held
93,204
-36.7% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Derivatives in VRDN
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$40,257
PutShares
2,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. VRDN ranks #69 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in VRDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,823,069 | 93,204 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,584,472 | 147,316 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,284,889 | 105,880 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,115,337 | 79,781 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,028,967 | 76,333 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,235,447 | 64,447 | Shares | Defined | 2025-02-13 | |
| 2024-12-31 | $40,257 | 2,100 | Put | Defined | 2025-02-13 | |
| 2024-09-30 | $1,114,840 | 49,004 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $487,327 | 37,458 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $562,559 | 32,128 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $563,948 | 25,893 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,111,059 | 72,429 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,638,820 | 68,887 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,169,171 | 45,958 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $16,571 | 808 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,103 | 614 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,749 | 311 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,608 | 486 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,777 | 412 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,491 | 519 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,187 | 490 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||